May
05
Meda AB (publ) – Interim report January-March 2009 – MarketWatch (press release)
By|
Meda AB (publ) – Interim report January-March 2009
MarketWatch (press release) Aldara (actinic keratosis treatment) totaled SEK 121 million (90), a 35% increase compared to 2008. Soma (muscle relaxant) totaled SEK 120 million (66). Sales in local currency climbed 37%. Sales of the 250 mg strength on the US market demonstrated … |